Market Tracker

11/24 9:59am ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.49
Data as of 9:40am ET
 +0.08 / +1.25%
Today’s Change
6.30
Today|||52-Week Range
31.73
-57.94%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close6.41
Today’s open6.58
Day’s range6.45 - 6.58
Volume3,140
Average volume (3 months)43,050
Market cap$64.8M
Dividend yield--
Data as of 9:40am ET, 11/24/2014

Growth & Valuation

Earnings growth (last year)+1.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.26

Competitors

 Today’s
change
Today’s
% change
CBRXColumbia Laboratorie...-0.06-1.01%
IPCIIntelliPharmaCeutics...-0.01-0.36%
GLMDGalmed Pharmaceutica...+0.03+0.51%
KBIOKaloBios Pharmaceuti...+0.01+0.51%
Data as of 9:58am ET, 11/24/2014

Financials

Next reporting dateJanuary 28, 2015
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$0.00
Annual profit (last year)-$4.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts